Skip to main content

Table 2 Results in patients after WRBC transfusion, reported as mean (SD) or median (25–75%)

From: The effects of differing anticoagulant regimes on blood quality after cell salvage in coronary artery bypass grafting (CABG): a pilot study

Parameter

All (n = 38)

Citrate (n = 19)

Heparin (n = 19)

p-value

Fhb (mg/dL)

12.0 (9.0–18.3)

12.0 (9.0–18.0)

11.0 (9.0–19.0)

0.729

Iron (μg/dL)

89.5 (65.3–117.8)

76.0 (66.0–110.0)

94.0 (63.0–120.0)

0.470

Transferrin (g/l)

1.3 (1.1–1.6)

1.6 (1.1–1.6)

1.3 (1.2–1.5)

0.471

Ferritin (μg/l)

224.7 (150.86)

193.70 (136.39)

255.73 (161.72)

0.209

Hepcidin (ng/ml)

20.1 (11.5–29.2)

18.0 (9.4–21.8)

25.4 (12.6–29.7)

0.189

Haptoglobin (g/l)

0.49 (0.35–0.69)

0.49 (0.25–0.70)

0.52 (0.37–0.71)

0.722

INR

1.35 (1.27–1.45)

1.30 (1.26–1.42)

1.39 (1.27–1.46)

0.212

Pt (%)

62.0 (55.8–68.0)

66.0 (57.0–68.0)

59.0 (55.00–68.0)

0.234

aPTT (s)

33.4 (30.8–35.1)

33.7 (30.5–35.0)

33.1 (31.3–35.3)

0.885

IL-6 (pg/ml)

481.0 (365.0–757.8)

493.0 (200.0–697.0)

461.0 (378.3–896.8)

0.379

IL-8 (pg/ml)

17.7 (15.6–35.8)

19.8 (15.6–31.4)

15.7 (15.6–38.2)

0.606

IL-10 (pg/ml)

31.0 (18.4–56.3)

35.2 (19.3–52.4)

27.8 (12.7–71.8)

0.461

MPO (ng/ml)

114.1 (91.3–168.8)

92.5 (83.5–117.3)

129.9 (112.5–187.9)

0.019

  1. Bold value < than 0.05 i.e. statistically significant